Min Zou

928 total citations
27 papers, 640 citations indexed

About

Min Zou is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Min Zou has authored 27 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Min Zou's work include Adipose Tissue and Metabolism (5 papers), Liver physiology and pathology (3 papers) and Inflammatory Bowel Disease (3 papers). Min Zou is often cited by papers focused on Adipose Tissue and Metabolism (5 papers), Liver physiology and pathology (3 papers) and Inflammatory Bowel Disease (3 papers). Min Zou collaborates with scholars based in China, United States and Hong Kong. Min Zou's co-authors include Shiyun Pu, Jinhan He, Qinhui Liu, Yanping Li, Tong Wu, Wei Jiang, Jiangying Kuang, Shihai Cheng, Xuping Yang and Jinhang Zhang and has published in prestigious journals such as Diabetes, Journal of Controlled Release and American Journal Of Pathology.

In The Last Decade

Min Zou

25 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Zou China 13 234 202 192 117 99 27 640
Ya Huang China 12 99 0.4× 150 0.7× 173 0.9× 99 0.8× 62 0.6× 23 525
Cuiyuan Huang China 14 96 0.4× 176 0.9× 204 1.1× 115 1.0× 66 0.7× 32 640
Néstor Vázquez-Agra Spain 6 60 0.3× 445 2.2× 233 1.2× 98 0.8× 24 0.2× 23 687
Zhen Sun China 17 119 0.5× 170 0.8× 319 1.7× 101 0.9× 13 0.1× 41 812
Mingwei Sheng China 15 61 0.3× 187 0.9× 308 1.6× 148 1.3× 26 0.3× 45 768
Heng Fan China 17 100 0.4× 103 0.5× 348 1.8× 83 0.7× 17 0.2× 54 818
Hongdi Cao China 17 89 0.4× 101 0.5× 496 2.6× 122 1.0× 39 0.4× 21 919
Yasutaka Inuzuka Japan 12 201 0.9× 111 0.5× 311 1.6× 71 0.6× 75 0.8× 29 752
Bankim A. Bhatt United States 10 233 1.0× 157 0.8× 149 0.8× 57 0.5× 11 0.1× 14 590

Countries citing papers authored by Min Zou

Since Specialization
Citations

This map shows the geographic impact of Min Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Zou more than expected).

Fields of papers citing papers by Min Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Zou. The network helps show where Min Zou may publish in the future.

Co-authorship network of co-authors of Min Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Min Zou. A scholar is included among the top collaborators of Min Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Zou. Min Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Juan, Hong Guo, & Min Zou. (2025). Research advances in nanomaterials with aromatic functional groups for the treatment of inflammatory bowel disease. Frontiers in Bioengineering and Biotechnology. 13. 1614939–1614939.
2.
Liu, Yixian, Xiaojun Zhang, Ying Zhao, et al.. (2025). Essential oils from Amorpha fruticosa against hepatocellular carcinoma based on network pharmacology. BMC Complementary Medicine and Therapies. 25(1). 29–29. 2 indexed citations
4.
Jin, Bo, Yixian Liu, Mengfei Wang, et al.. (2024). Polydopamine-Based Targeted Nanosystem for Chemo/Photothermal Therapy of Retinoblastoma in a Mouse Orthotopic Model. International Journal of Nanomedicine. Volume 19. 7799–7816. 1 indexed citations
5.
Tang, Jing, Kang Tang, Xiaoyan Ye, et al.. (2023). Susceptibility identification for seasonal influenza A/H3N2 based on baseline blood transcriptome. Frontiers in Immunology. 13. 1048774–1048774. 2 indexed citations
6.
Zou, Min, et al.. (2023). Comparison of the two surgery methods combined with accelerated rehabilitation in the treatment of lateral compression type 1 pelvic fractures in the elderly. Journal of Orthopaedic Surgery and Research. 18(1). 734–734. 2 indexed citations
7.
Zou, Min, et al.. (2023). Lactate dehydrogenase and the severity of adenoviral pneumonia in children: A meta-analysis. Frontiers in Pediatrics. 10. 1059728–1059728. 9 indexed citations
8.
Zou, Min, et al.. (2022). Prevalence and Associated Factors of Sexual Dysfunction in Patients With Inflammatory Bowel Disease. Frontiers in Endocrinology. 13. 881485–881485. 18 indexed citations
9.
Zhang, Jihui, et al.. (2022). Prevalence and risk factors of erectile dysfunction in COVID-19 patients: a systematic review and meta-analysis. Journal of Endocrinological Investigation. 46(4). 795–804. 14 indexed citations
10.
Shi, Wei, et al.. (2022). Diagnosis, prevalence, and outcomes of sarcopenia in kidney transplantation recipients: A systematic review and meta‐analysis. Journal of Cachexia Sarcopenia and Muscle. 14(1). 17–29. 29 indexed citations
11.
Zou, Min, Jiawen Li, Bo Jin, et al.. (2021). Design, synthesis and anticancer evaluation of new 4-anilinoquinoline-3-carbonitrile derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers. Bioorganic Chemistry. 114. 105200–105200. 16 indexed citations
12.
Pu, Shiyun, Yanping Li, Qinhui Liu, et al.. (2021). Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis. Frontiers in Pharmacology. 12. 628583–628583. 17 indexed citations
13.
Hu, Yan, Siying Ren, Chao Zeng, et al.. (2021). Case Report: Surgical Therapy for Left Innominate Vein Aneurysm Under Thoracoscopy. Frontiers in Surgery. 8. 741840–741840.
14.
Yang, Xuping, Qinhui Liu, Yanping Li, et al.. (2020). The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway. Adipocyte. 9(1). 484–494. 138 indexed citations
15.
Li, Yanping, Shiyun Pu, Qinhui Liu, et al.. (2019). An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis. Journal of Controlled Release. 303. 77–90. 81 indexed citations
16.
Li, Hong, Jing Shen, Tong Wu, et al.. (2019). Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis. Frontiers in Pharmacology. 10. 548–548. 27 indexed citations
17.
Li, Chenshuang, et al.. (2019). Fibromodulin – A New Target of Osteoarthritis Management?. Frontiers in Pharmacology. 10. 1475–1475. 9 indexed citations
18.
Cheng, Shihai, Min Zou, Qinhui Liu, et al.. (2017). Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation. American Journal Of Pathology. 187(4). 808–818. 29 indexed citations
19.
Mo, Li, Jing Shen, Qinhui Liu, et al.. (2016). Irisin Is Regulated by CAR in Liver and Is a Mediator of Hepatic Glucose and Lipid Metabolism. Molecular Endocrinology. 30(5). 533–542. 71 indexed citations
20.
Zou, Min, et al.. (2012). [Left ventricular function in newborn infants of mothers with gestational diabetes mellitus].. PubMed. 14(8). 575–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026